New consultancy set up for EU directives:
This article was originally published in Clinica
The companies EMDC, Factory, BioScan and Q-Serve have jointly set up a new 48-person strong consultancy group offering services on compliance with the European Union's medical devices directives from preclinical testing to post-market surveillance. The MEDDEV multilingual group has offices in the Netherlands, Switzerland and the US and also assists with compliance with US laws. For more information see the following website: www.meddevgroup.com.
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.